Broad Potential of Synap Biotech’s Platform

Broad Potential of Synap Biotech’s Platform:

• Targeting Nogo-A enhances neuroplasticity, promoting functional recovery in brain injuries and neurodegenerative diseases.

• TBI & CTE: Supports brain repair in sports-related and military-related traumatic brain injuries.

• Stroke Recovery: Accelerates neuronal regeneration, improving long-term functional outcomes.

• Neurodegenerative Diseases: Potential applications in Alzheimer’s, Parkinson’s, ALS, and Multiple Sclerosis, addressing barriers to brain repair.

• Versatile & Scalable: A platform technology with the potential to transform neurological rehabilitation across multiple conditions.